U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199309) titled 'A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol' on Sept. 22.
Brief Summary: The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Hypertriglyceridemia
Intervention:
DRUG: MAR001
Subcutaneous Injection
DRUG: Placebo
Subcutaneous Injection
Recruitment Status: RECRUITING
Sponsor: Marea Therapeutics
Published by HT Digital Content Services with permission from Health Daily Digest....